Emory Winship Cancer Institute | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
Emory Winship Cancer Institute

Emory Winship Cancer Institute

1365-C Clifton Road NE
Atlanta, Georgia, United States
Phone   Web  

At Emory Winship Cancer Institute, we provide exceptional expertise in the management of a variety of plasma cell disorders, and diseases related to plasma cell abnormalities. Our specialists in the plasma cell dyscrasia program at Winship are ready to provide you with the most advanced treatment options available today. 

There are several differing types of plasma cell disorders, or diseases related to plasma cell abnormalities. In our clinic, we treat patients with any one of the following:

• amyloid light-chain (AL) amyloidosis: Proteins produced by cancerous plasma cells take a particular form that allows them to be deposited into various body organs, such as kidney, heart or others, causing damage.

• monoclonal gammopathy of renal significance (MGRS)

• POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, & Skin changes)

• Cryoglobulinemia

The team includes healthcare professionals in the following areas:

Hematology and Oncology:
Jonathan L. Kaufman, MD; Craig C. Hofmeister, MD, MPH

Gastroenterology:
Nikrad Shahnavaz, MD

Cardiology:
Kunal Bhatt, MD

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close